LEGISLATIVE SERVICES AGENCY
OFFICE OF FISCAL AND MANAGEMENT ANALYSIS
FISCAL IMPACT STATEMENT
LS 6194 NOTE PREPARED: Oct 29, 2024
BILL NUMBER: HB 1376 BILL AMENDED:
SUBJECT: Opioid Overdose Reversal Medication in Schools.
FIRST AUTHOR: Rep. Boy BILL STATUS: As Introduced
FIRST SPONSOR:
FUNDS AFFECTED:XGENERAL IMPACT: State & Local
DEDICATED
FEDERAL
Summary of Legislation: This bill sets forth certain requirements concerning FDA approved opioid
overdose reversal medication.
Effective Date: July 1, 2025.
Explanation of State Expenditures: The bill requires the State Health Commissioner or their designee to
issue a statewide standing order or prescription for certain opioid overdose reversal medications. This is
within the agency’s routine administrative functions and should be able to be implemented with no additional
appropriations, assuming near customary agency staffing and resource levels.
Explanation of State Revenues:
Explanation of Local Expenditures: Beginning in FY 2026, provisions in the bill are estimated to increase
statewide expenditures for traditional school corporations by an estimated $90,000 to stock the necessary
amount of opioid overdose reversal medication. Schools may experience additional costs to provide storage
for the medications and to refill the school’s inventory as needed. Expenditures would decrease dependent
on the amount of opioid overdose reversal medication schools currently have in storage and to the extent that
schools are able to partner with organizations offering free naloxone.
Additional Information - Narcan is a popular brand name for naloxone, which is a common opioid overdose
reversal medication. Narcan is produced by Emergent Biosolutions, who offers the drug at a public interest
rate of $41 per carton. Each carton contains two doses of the drug and has a shelf life of four years. Schools
are currently authorized, but not required, to stock naloxone. Dependent on the amount of naloxone schools
currently have in stock, school expenditures may be lower than projected.
U.S. high schools are also eligible to receive two free cartons of Narcan through Emergent Biosolutions’ Free
Goods Program. LSA assumed all eligible schools would participate in the Free Goods Program when
calculating the estimated total cost for public schools. Indiana schools may further decrease expenditures by
partnering with an opioid prevention organization. For example, schools who partner with Overdose Lifeline
HB 1376 1 may receive free naloxone from the organization’s Indiana School Naloxone Project which distributed 544
naloxone kits to school districts in 2023.
Explanation of Local Revenues:
State Agencies Affected:
Local Agencies Affected: Public schools.
Information Sources: Overdose Lifeline, 2023 Annual Report.
https://www.overdoselifeline.org/achievements/;
Emergent Biosolutions,
https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-nar
canr-nasal-spray-launches-over-counter#:~:text=To%20that%20end%2C%20Emergent%20has,available
%20to%20at%2Drisk%20communities;
National Overdose Prevention Network, https://nopn.org/resources/free-narcan-nasal-spray-for-eligible-
schools;
Food & Drug Administration,
https://www.fda.gov/drugs/drug-safety-and-availability/fda-announces-shelf-life-extension-naloxone-nas
al-spray;
Fiscal Analyst: Kelan Fong, 317-232-9592.
HB 1376 2